Companies / Venezuela
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Pfizer Targets Influenza Market
September 2006 | Product LaunchSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
US drug major Pfizer is to target a 5% share of Venezuela's US$40mn market for influenza treatments, and expects to launch its Atamel Grip line extension in the next 24 months. The four leading brands Teragrip, Alivet, Coricidin and Ilvico account for 75% of the country's influenza market. Local data indicate that 43% of available flu products are in solid form, with 43% soluble powders and 17%